Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

JP Morgan Initiates Coverage On Senti Biosciences with Neutral Rating

JP Morgan analyst Brian Cheng initiates coverage on Senti Biosciences (NASDAQ:SNTI) with a Neutral rating.

byBenzinga Newsdesk

December 16, 2022

1 minute read

JP Morgan analyst Brian Cheng initiates coverage on Senti Biosciences (NASDAQ:SNTI) with a Neutral rating.

Cantor Fitzgerald Maintains Neutral on Jushi Holdings, Lowers Price Target to $5.25

By Benzinga Newsdesk

August 4, 5:50 AM

Cantor Fitzgerald analyst Pablo Zuanic maintains Jushi Holdings (OTC:JUSHF) with a Neutral and lowers the price target from $6.15 to $5.25.

JUSHF

Caesars Entertainment Named Sports Betting Partner, Official Casino Partner Of Indianapolis Colts

By Benzinga Newsdesk

September 16, 1:05 PM

The Indianapolis Colts and Caesars Entertainment, Inc. (NASDAQ:CZR) today announced a partnership making Caesars Sportsbook a premier sports betting partner and the only official casino partner of the

CZR

Benzinga’s Top Ratings Upgrades, Downgrades For June 14, 2021

By Benzinga Insights

June 14, 10:47 AM

ATLC

Analyst Ratings

What 6 Analyst Ratings Have To Say About Tenet Healthcare

By Benzinga Insights

February 10, 4:01 PM

Tenet Healthcare (NYSE:THC) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

THC

JP Morgan Initiates Coverage On Senti Biosciences with Neutral Rating

Related Posts

Cantor Fitzgerald Maintains Neutral on Jushi Holdings, Lowers Price Target to $5.25

Caesars Entertainment Named Sports Betting Partner, Official Casino Partner Of Indianapolis Colts

Benzinga’s Top Ratings Upgrades, Downgrades For June 14, 2021

What 6 Analyst Ratings Have To Say About Tenet Healthcare